Abstract
Central neurocytoma is a rare brain tumor usually in young adults, which arises most commonly in the supratentorial ventricular system. It frequently causes obstructive hydrocephalus and symptoms of increased intracranial pressure. Diagnosis is made based on characteristic pathologic findings consistent with neuronal differentiation including immunoreactivity with antibody to synaptophysin. Treatment paradigms include maximal safe surgical resection or definitive radiotherapy. After surgical resection, adjuvant radiotherapy may be indicated in the event of subtotal resection or if adverse pathologic features such as elevated MIB-1 labeling index are identified. In general, radiation therapy may be prescribed as conventionally fractionated radiotherapy to doses of 45–54 Gy at 1.8–2.0 Gy/fx for benign neurocytomas or 54–60 Gy in 2.0 Gy/fx for atypical neurocytomas. Stereotactic radiosurgery experiences have used mean marginal doses ranging from 10.5 to 20 Gy, though the majority were treated with mean marginal doses of 14–18 Gy in a single fraction. Local control is favorable with these therapies. After completion of radiotherapy, patients should be followed in the long term to evaluate for potential recurrences and radiation-induced late toxicities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hassoun J, Gambarelli D, Grisoli F, et al. Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol. 1982;56(2):151–6.
Kim DG, Park CK. Central neurocytoma: establishment of the disease entity. Neurosurg Clin N Am. 2015;26(1):1–4.
Schmidt MH, Gottfried ON, von Koch CS, et al. Central neurocytoma: a review. J Neurooncol. 2004;66(3):377–84.
Patel DM, Schmidt RF, Liu JK. Update on the diagnosis, pathogenesis, and treatment strategies for central neurocytoma. J Clin Neurosci. 2013;20(9):1193–9.
Yang I, Ung N, Chung LK, et al. Clinical manifestations of central neurocytoma. Neurosurg Clin N Am. 2015;26(1):5–10.
Wong J, Teo C, Kwok B. Central neurocytoma in third and fourth ventricles with aqueductal involvement. Br J Neurosurg. 2006;20(1):57–62.
Donoho D, Zada G. Imaging of central neurocytomas. Neurosurg Clin N Am. 2015;26(1):11–9.
Choudhari KA, Kaliaperumal C, Jain A, et al. Central neurocytoma: a multi-disciplinary review. Br J Neurosurg. 2009;23(6):585–95.
Paek SH, Kim JE, Kim DG, et al. Angiographic characteristics of central neurocytoma suggest the origin of tumor. J Korean Med Sci. 2003;18(4):573–80.
Rades D, Schild SE, Fehlauer F. Prognostic value of the MIB-1 labeling index for central neurocytomas. Neurology. 2004;62(6):987–9.
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109.
Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20.
Soylemezoglu F, Scheithauer BW, Esteve J, et al. Atypical central neurocytoma. J Neuropathol Exp Neurol. 1997;56(5):551–6.
Sgouros S, Carey M, Aluwihare N, et al. Central neurocytoma: a correlative clinicopathologic and radiologic analysis. Surg Neurol. 1998;49(2):197–204.
Cobery ST, Noren G, Friehs GM, et al. Gamma knife surgery for treatment of central neurocytomas. Report of four cases. J Neurosurg. 2001;94(2):327–30.
Qian H, Lin S, Zhang M, et al. Surgical management of intraventricular central neurocytoma: 92 cases. Acta Neurochir. 2012;154(11):1951–60.
Imber BS, Braunstein SE, Wu FY, et al. Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J Neurooncol. 2016;126(1):193–200.
Rades D, Fehlauer F. Treatment options for central neurocytoma. Neurology. 2002;59(8):1268–70.
Rades D, Fehlauer F, Schild SE. Treatment of atypical neurocytomas. Cancer. 2004;100(4):814–7.
Rades D, Fehlauer F, Lamszus K, et al. Well-differentiated neurocytoma: what is the best available treatment? Neuro Oncol. 2005;7(1):77–83.
Rades D, Schild SE. Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas. Cancer. 2006;106(5):1140–3.
Kim DG, Paek SH, Kim IH, et al. Central neurocytoma: the role of radiation therapy and long term outcome. Cancer. 1997;79(10):1995–2002.
Park HK, Steven DC. Stereotactic radiosurgery for central neurocytoma: a quantitative systematic review. J Neurooncol. 2012;108(1):115–21.
Rades D, Fehlauer F, Ikezaki K, et al. Dose-effect relationship for radiotherapy after incomplete resection of atypical neurocytomas. Radiother Oncol. 2005;74(1):67–9.
Louis DN, Swearingen B, Linggood RM, et al. Central nervous system neurocytoma and neuroblastoma in adults—report of eight cases. J Neurooncol. 1990;9(3):231–8.
Fujimaki T, Matsuno A, Sasaki T, et al. Proliferative activity of central neurocytoma: measurement of tumor volume doubling time, MIB-1 staining index and bromodeoxyuridine labeling index. J Neurooncol. 1997;32(2):103–9.
Sharma MC, Sarkar C, Karak AK, et al. Intraventricular neurocytoma: a clinicopathological study of 20 cases with review of the literature. J Clin Neurosci. 1999;6(4):319–23.
Ashkan K, Casey AT, D’Arrigo C, et al. Benign central neurocytoma. Cancer. 2000;89(5):1111–20.
Lenzi J, Salvati M, Raco A, et al. Central neurocytoma: a novel appraisal of a polymorphic pathology. Our experience and a review of the literature. Neurosurg Rev. 2006;29(4):286–92. discussion 292
Leenstra JL, Rodriguez FJ, Frechette CM, et al. Central neurocytoma: management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys. 2007;67(4):1145–54.
Paek SH, Han JH, Kim JW, et al. Long-term outcome of conventional radiation therapy for central neurocytoma. J Neurooncol. 2008;90(1):25–30.
Chen CM, Chen KH, Jung SM, et al. Central neurocytoma: 9 case series and review. Surg Neurol. 2008;70(2):204–9.
Pollock BE, Stafford SL. Stereotactic radiosurgery for recurrent central neurocytoma: case report. Neurosurgery. 2001;48(2):441–3.
Bertalanffy A, Roessler K, Dietrich W, et al. Gamma knife radiosurgery of recurrent central neurocytomas: a preliminary report. J Neurol Neurosurg Psychiatry. 2001;70(4):489–93.
Anderson RC, Elder JB, Parsa AT, et al. Radiosurgery for the treatment of recurrent central neurocytomas. Neurosurgery. 2001;48(6):1231–7. discussion 1237–8
Martin JM, Katati M, Lopez E, et al. Linear accelerator radiosurgery in treatment of central neurocytomas. Acta Neurochir. 2003;145(9):749–54. discussion 754
Hara M, Aoyagi M, Yamamoto M, et al. Rapid shrinkage of remnant central neurocytoma after gamma knife radiosurgery: a case report. J Neurooncol. 2003;62(3):269–73.
Kim CY, Paek SH, Jeong SS, et al. Gamma knife radiosurgery for central neurocytoma: primary and secondary treatment. Cancer. 2007;110(10):2276–84.
Yen CP, Sheehan J, Patterson G, et al. Gamma knife surgery for neurocytoma. J Neurosurg. 2007;107(1):7–12.
Matsunaga S, Shuto T, Suenaga J, et al. Gamma knife radiosurgery for central neurocytomas. Neurol Med Chir. 2010;50(2):107–12. disucussion 112–3
Genc A, Bozkurt SU, Karabagli P, et al. Gamma knife radiosurgery for cranial neurocytomas. J Neurooncol. 2011;105(3):647–57.
Karlsson B, Guo WY, Kejia T, et al. Gamma knife surgery for central neurocytomas. J Neurosurg. 2012;117(Suppl):96–101.
Monaco EA 3rd, Niranjan A, Lunsford LD. The management of central neurocytoma: radiosurgery. Neurosurg Clin N Am. 2015;26(1):37–44.
Yamanaka K, Iwai Y, Shuto T, et al. Treatment results of gamma knife radiosurgery for central neurocytoma: report of a Japanese multi-institutional cooperative study. World Neurosurg. 2016;90:300–5.
Lawrence YR, Li XA, el Naqa I, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S20–7.
Douw L, Klein M, Fagel SS, et al. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol. 2009;8(9):810–8.
Barani IJ, Raleigh DR, Larson D. The management of central neurocytoma: radiotherapy. Neurosurg Clin N Am. 2015;26(1):45–56.
Kim JW, Kim DG, Kim IK, et al. Central neurocytoma: long-term outcomes of multimodal treatments and management strategies based on 30 years’ experience in a single institute. Neurosurgery. 2013;72(3):407–13. discussion 413–4
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Parsai, S., Gandhidasan, S., Suh, J.H. (2018). Central Neurocytoma. In: Chang, E., Brown, P., Lo, S., Sahgal, A., Suh, J. (eds) Adult CNS Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-42878-9_29
Download citation
DOI: https://doi.org/10.1007/978-3-319-42878-9_29
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42877-2
Online ISBN: 978-3-319-42878-9
eBook Packages: MedicineMedicine (R0)